Secretory phospholipase A2 enzymes as pharmacological targets for treatment of disease
about
Marine Natural Product Inhibitors of Neutrophil-Associated InflammationPhospholipase A2 - nexus of aging, oxidative stress, neuronal excitability, and functional decline of the aging nervous system? Insights from a snail model system of neuronal aging and age-associated memory impairmentSerine dipeptide lipids of Porphyromonas gingivalis inhibit osteoblast differentiation: Relationship to Toll-like receptor 2A dangerous liaison: Leptin and sPLA2-IIA join forces to induce proliferation and migration of astrocytoma cellsDevelopment of a potent 2-oxoamide inhibitor of secreted phospholipase A2 guided by molecular docking calculations and molecular dynamics simulations.The Lipoxygenases: Their Regulation and Implication in Alzheimer's Disease.Diverse Molecular Targets for Chalcones with Varied Bioactivities.Structural Insight into Binding Mode of 9-Hydroxy Aristolochic Acid, Diclofenac and Indomethacin to PLA2.Macrophages and Phospholipases at the Intersection between Inflammation and the Pathogenesis of HIV-1 Infection.Structural basis for functional selectivity and ligand recognition revealed by crystal structures of human secreted phospholipase A2 group IIE.Lipopolysaccharide potentiates platelet responses via toll-like receptor 4-stimulated Akt-Erk-PLA2 signalling.Epigenetic control of group V phospholipase A2 expression in human malignant cells.Can Inhibitors of Snake Venom Phospholipases A₂ Lead to New Insights into Anti-Inflammatory Therapy in Humans? A Theoretical Study.New quinoxalinone inhibitors targeting secreted phospholipase A2 and α-glucosidase.Association of type II secretory phospholipase A2 and surfactant protein D with the pulmonary oxygenation potential in patients with septic shock during polymyxin-B immobilized fiber-direct hemoperfusion.State of the Art of Stimuli-Responsive Liposomes for Cancer Therapy.Sphingomyelin Regulates the Activity of Secretory Phospholipase A2 in the Plasma Membrane.Plasma phospholipase A2 activity may serve as a novel diagnostic biomarker for the diagnosis of breast cancer.pCRP-mCRP Dissociation Mechanisms as Potential Targets for the Development of Small-Molecule Anti-Inflammatory Chemotherapeutics.
P2860
Q26740528-C34C8211-78C6-4E48-974D-EB098A45E117Q34630947-B3EDE923-7F11-4BF1-8B3A-CB7D2BB66B4EQ36269310-44D4C53B-C7D6-41A8-9A16-23E19303973DQ36294159-507178F8-9E0D-4DD2-9D91-9766165324E5Q37624745-2E307A3F-1499-4325-9C41-F2B8A3674640Q38671719-196C6CED-6573-4894-9877-BEABA264EEF3Q38707609-500B2A11-F77A-456B-A51F-E67F3EE2F550Q39160525-95AF2D4F-053B-45EA-9FF0-6483DE717874Q39404652-81AE871E-6DD0-4C9C-90C1-2DD53DA5497FQ41534911-8566363F-92B4-4901-A8EB-A9FD5BE5F0FCQ46261707-A11B9C4D-2568-47C6-BB83-157EEF19F95AQ46301356-671A2109-BDDC-443B-B29F-53070C92957DQ47135399-59FA6CD1-F4C0-4D31-A6F4-6040D135723CQ50252284-01A278C7-0EDC-4897-B23B-91D725168936Q51456273-39ECD4B4-7A35-4AF1-A670-E1A3C4779D61Q51738726-6140222B-214B-4144-987D-06D8CA752CEEQ51744373-7FB8D78F-297A-423B-AD44-DC29793050DFQ52655121-368FB2C3-0C5B-4A95-846D-3D06832A9060Q55044803-F646AC84-1A8E-4408-B692-2818120510E0
P2860
Secretory phospholipase A2 enzymes as pharmacological targets for treatment of disease
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Secretory phospholipase A2 enzymes as pharmacological targets for treatment of disease
@ast
Secretory phospholipase A2 enzymes as pharmacological targets for treatment of disease
@en
type
label
Secretory phospholipase A2 enzymes as pharmacological targets for treatment of disease
@ast
Secretory phospholipase A2 enzymes as pharmacological targets for treatment of disease
@en
prefLabel
Secretory phospholipase A2 enzymes as pharmacological targets for treatment of disease
@ast
Secretory phospholipase A2 enzymes as pharmacological targets for treatment of disease
@en
P2860
P1476
Secretory phospholipase A2 enzymes as pharmacological targets for treatment of disease
@en
P2093
Brian S Cummings
Nhat D Quach
P2860
P304
P356
10.1016/J.BCP.2014.05.022
P407
P577
2014-06-04T00:00:00Z